Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant units » significant anti (Expand Search), significant bias (Expand Search), significant insights (Expand Search)
units decrease » units increased (Expand Search), unit increase (Expand Search), visits decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant units » significant anti (Expand Search), significant bias (Expand Search), significant insights (Expand Search)
units decrease » units increased (Expand Search), unit increase (Expand Search), visits decreased (Expand Search)
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
Simulated and measured S-parameters comparison of miniaturized MIMO mobile terminal antenna.
Published 2025Subjects: -
32
-
33
-
34
-
35
-
36
-
37
-
38
Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).
Published 2025“…<p>Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (significant decrease)).…”
-
39
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
40
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”